Arrowhead Pharmaceuticals, INC. (ARWR) SEC Filings — 2025
13 SEC filings for Arrowhead Pharmaceuticals, INC. (ARWR) in 2025.
Filings
- Arrowhead Launches First Commercial Drug, Eyes sHTG Expansion — 10-K · Nov 25, 2025
- Arrowhead Pharmaceuticals, INC. 8-K Filing — 8-K · Nov 18, 2025
- Arrowhead Amends 10-K for Governance Details, No Financial Changes — 10-K/A · Oct 10, 2025
- Arrowhead Pharma inks $1.2B deal with Horizon for plozasiran — 8-K · Sep 12, 2025
- Arrowhead Pharmaceuticals, INC. 8-K Filing — 8-K · Sep 11, 2025
- Arrowhead Pharmaceuticals Files 8-K Report — 8-K · Sep 2, 2025
- Arrowhead's Q3 Loss Widens on Higher R&D, Revenue Declines — 10-Q · Aug 7, 2025
- Arrowhead Pharmaceuticals Files 10-Q for Q2 2025 — 10-Q · May 12, 2025
- Arrowhead Pharma Reports Executive & Director Changes — 8-K · Apr 15, 2025
- Arrowhead Pharmaceuticals Files 8-K — 8-K · Mar 19, 2025
- Arrowhead Pharma Files Q4 2024 Report — 10-Q · Feb 10, 2025
- Arrowhead Pharma Files 8-K: Board & Executive Compensation Changes — 8-K · Feb 7, 2025
- Arrowhead Pharma Files DEF 14A on Executive Compensation — DEF 14A · Jan 29, 2025